Skip to Main Content

HelixTalk Episode #33 - PCSK9 Inhibitors

Date posted: October 13, 2015, 6:00 am

In this episode, we discuss PCSK9 inhibitors, a new drug class for LDL lowering, with a particular focus on alirocumab (Praluent).